2 completed, 1 terminated. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Terminated 1 |
Follow phenylacetic acid: new trials by email Literature Review of phenylacetic acid trials Research Report on phenylacetic acid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety Study of Ammonul® in Patients With Grade 3 or 4 Hepatic Encephalopathy sodium phenylacetate and sodium benzoate injection 10% / 10%, placebo solution (10% dextrose) - Hepatic Encephalopathy | Phase 2 | Terminated | Amgen | 1 | 2007-12-01 | 2024-12-17 |
| Phenylacetate in Treating Children With Recurrent or Progressive Brain Tumors phenylacetate - Brain and Central Nervous System Tumors | Phase 2 | Completed | Texas Children's Cancer Center | 1998-05-01 | 2013-06-26 | |
| Phase II Study of Sodium Phenylbutyrate, Sodium Benzoate, Sodium Phenylacetate, and Dietary Intervention for Urea Cycle Disorders Sodium Benzoate, Sodium Phenylacetate, Sodium Phenylbutyrate - Amino Acid Metabolism, Inborn Errors | Phase 2 | Completed | National Center for Research Resources (NCRR) | 20 | 1985-01-01 | 2005-06-24 |
Amino Acid Metabolism, Inborn Errors (1) · Astrocytoma (1) · Central Nervous System Neoplasms (1) · Familial ependymoma (1) · Hepatic Encephalopathy (1) · Lymphoma, Follicular (1) · Medulloblastoma (1) · Metabolism, Inborn Errors (1) · Rare Diseases (1) · Urea Cycle Disorders, Inborn (1)
Amgen (1) · National Center for Research Resources (NCRR) (1) · Texas Children's Cancer Center (1)
United States (2)
Lisa Bomgaars, MD (1) · Saul W. Brusilow (1)